Roche test gets FDA emergency use endorsement for COVID-19 patients Kumar Jeetendra | June 4, 2020 Drugmaker Roche has gotten emergency use authorisation from the U.S. Food and Drug Administration for its Elecsys IL-6 test to help distinguish serious provocative reaction in patients with affirmed COVID-19, it said on Thursday. The test can be utilized to help distinguish coronavirus patients who could be at high danger of intubation with mechanical ventilation, …
The corona outbreak has provided us with a unique opportunity: An interview with Mr. Jatin Mahajan, MD, J Mitra and Co. Kumar Jeetendra | June 4, 2020 J. Mitra and Co. Pvt Ltd is one of the pioneer Indian in-vitro-diagnostic Company, to get drug manufacturing licenses for critical in-vitro diagnostic tests like HIV, HBV, HCV in rapid and ELISA formats in India. It presented with the innovation of differential detection of HIV 1 and HIV 2 in single rapid kit format. These …
An Interview with Dr. Gangadhar Motiram Warke: Founder of HiMedia Laboratories Kumar Jeetendra | June 4, 2020 HiMedia Laboratories, a leading bioscience company, with its global presence in more than 150 countries and is amongst the top three brands in microbiology in the world and has been conferred with a Pride of Maharashtra award in the year 2019 by Maharashtra Industrial and Economic Development (MIEDA) under the category “Best Company of the …
COVID-19 limitations influenced sales, made liquidity crunch: Lyka Labs Kumar Jeetendra | June 5, 2020 Pharmaceutical firm Lyka Labs on Friday said the coronavirus-incited lockdown adversy affected deals, made liquidity crunch and the organization’s presentation keeps on being influenced by COVID-19 limitations. In an administrative recording uncovering the effect of COVID-19, Lyka Labs said in spite of the fact that the legislature permitted pharma firms to work during the lockdown, …
Sun Pharma testing plant-based medication as potential COVID-19 treatment Kumar Jeetendra | June 5, 2020 Indian drugmaker Sun Pharmaceutical Industries Ltd said on Friday it was trying a plant-determined medication, AQCH, for the potential treatment of COVID-19 as a major aspect of a mid-stage preliminary, with results expected by October. AQCH is gotten from tropical, climbing bush cocculus hirsutus, which is utilized in Asia for its clear therapeutic properties. The …
Priorclave recieved Saudi Arabian FDA Approval for its Autoclaves Kumar Jeetendra | June 5, 2020 As a main British autoclave maker, Priorclave is charmed to report that it has picked up endorsement by the SFDA-Saudi Food and Drug Authority for its whole range of research grade lab autoclaves. This is a significant turn of events and will empower the organization to additionally extend its business in the region. Priorclave has …
Zydus Cadila gets last endorsement from USFDA for Atazanavir Capsules Kumar Jeetendra | June 5, 2020 Zydus Cadila has gotten final endorsement from the USFDA to showcase Atazanavir Capsules (US RLD: Reyataz™ Capsules) in the qualities of 150 mg, 200 mg and 300 mg. Atanazavir, an antiretroviral medicate, is utilized to treat contamination of the Human Immunodeficiency Virus (HIV). It is utilized in blend with other antiretroviral medications to treat HIV-1 …
Atomic Absorption Spectroscopy in drug testing and analysis Kumar Jeetendra | June 5, 2020 To ensure the safety, quality and efficacy of compounds being produced, USP has developed standards and guidelines that must be observed by the pharmaceutical industry. Preferences of UV/Vis Spectroscopy Simple to utilize Straight forward structure of instrument utilizes the light from a specific light to go through the example Quick outcomes Rapidly investigates HPLC (High-performance …
WHO proceeds with hydroxychloroquine preliminary after UK test stops Kumar Jeetendra | June 6, 2020 The World Health Organization (WHO) is proceeding with its clinical preliminary of hydroxychloroquine, after British researchers ended an enormous preliminary that had been investigating utilization of the medication to treat patients with COVID-19 when beginning outcomes indicated no proof of advantage. “There are two unmistakable preliminaries with their own conventions, their own oversight advisory groups. …
Maharashtra govt will acquire 10,000 vials of Remdesivir to treat COVID-19 patients: Tope Kumar Jeetendra | June 6, 2020 The Maharashtra government will acquire 10,000 vials of the medication Remdesivir for rewarding coronavirus patients, Public Health Minister Rajesh Tope said on Saturday. The costly medication is being made accessible for poor people and penniless patients in the state, he said. “GoM to obtain 10k vials of Remdesivir. In view of proof from research facility, …
COVID-19 patients with extreme pneumonia ought to be considered for moving to ICU: Protocol Kumar Jeetendra | June 7, 2020 Suggestive COVID-19 patients who have “extreme pneumonia” with a respiratory pace of 30 breath for every moment ought to be considered for moving to ICU, as indicated by a clinical administration convention for grown-up patients experiencing the malady. A COVID-19 patient with cut off pneumonia likewise has an oxygen immersion level (Spo2) of under 90 …
Researchers close ‘discovery’ on antibody treatment Kumar Jeetendra | June 7, 2020 In the midst of the coronavirus pandemic, which has contaminated in excess of 69 lakh individuals and slaughtered more than four lakh over the world, researchers might be near a discovery on a neutralizer treatment that can spare the lives of individuals tainted with the lethal infection, The Guardian has revealed. The researchers have built …
